The Australasian Professional Society on Alcohol and other Drugs

News & Media

Job opportunity: Program Manager Goulburn Valley Alcohol and Drug Service 

Program Manager Goulburn Valley Alcohol and Drug Service - Applications close: 18 March 2021

  • Permanent Full Time with monthly ADO
  • Based at Community Health @GV Health, Corio St, Shepparton
  • Relocation support and transition available

 About GV Health

At GV Health we are so much more than a regional health service. As the largest employer in the region, we work with purpose and pride and are committed to respecting and embracing diversity, inclusion and accessibility for our people and community.

It is an exciting time to join our GV Health team! We are currently in the midst of an exciting $229 million transformation of our Graham Street site, which comprises of a five-storey Inpatient Unit building, expansion of our current theatre capacity, new Critical Care Unit, a state of-the-art Dialysis Unit and an extension of the current Emergency Department.

To find our more information about GV Health please visit http://www.gvhealth.org.au/

About the role

GV Health is seeking an exceptional individual to lead and manage the Goulburn Valley Alcohol and Drug Service (GVADS) which is an integrated consortium delivered service that provides a range of AOD services including counselling, day rehabilitation, withdrawal and addiction medicine services in the West Hume region.

In this role you would be responsible for strategic planning, program development and delivery, professional standards of care, program outcomes and reporting requirements.  You will work with a dedicated clinical team, including an addiction medicine specialist providing you with the opportunity to use your knowledge and skills to grow and further develop an established AOD service.

To be successful in the role you will need to be a skilled, creative person who has a passion for building sector capabilities and delivering high quality, innovative services that respond to people who are affected by drugs and alcohol.

 

We are looking for

  • An experienced health professional with substantial experience in, and knowledge of the AOD sector
  • High level skills in service planning and development
  • Experience in leading and building the capacity of teams and individuals
  • Outstanding communication skills

Our offer to you

  • Relocation and transition support if moving to the Shepparton region
  • Generous salary packaging, subsidised staff parking and discounted leisure memberships
  • Flexible work practices and options to purchase additional leave to help create some important work/life balance
  • Professional development and study leave to help reach your learning and career goals
  • If relocating to the Shepparton region a dedicated resource to support with your transition

Learn more

For further information please contact Sally Belcher on 0457 932 676 or This email address is being protected from spambots. You need JavaScript enabled to view it.

To apply visit:  GV Health : eRecruit (mercury.com.au)

Applications close: 18 March 2021

 

Opportunity available for a Clinical Nurse Consultant

A vacancy exists at St Vincent’s Hospital Sydney for a Clinical Nurse Consultant (Grade 2) position to work with the Drug and Alcohol Specialist Advisory Service (DASAS).

  • ·The Clinical Nurse Consultant is responsible for the provision of comprehensive drug and alcohol clinical consultancy and determining appropriate solutions to queries, including providing accurate advice, to health professionals within their scope of practice. The Clinical Nurse Consultant will be the main point of contact for DASAS and will work in collaboration with Alcohol and Drug Staff Specialists and Counsellors. The CNC will carry out their duties while working in tandem with the Hospital Drug and Alcohol Consultation Liaison (HDA-CL) in the assessment and management of patients with drug and alcohol related conditions during hospital presentations and/or during care.

The position is 16 hours per week, maximum term until 30 June 2022.

Link to advertisement - https://svha.wd3.myworkdayjobs.com/SVHA_Sydney_Public/job/Darlinghurst-Sydney/Clinical-Nurse-Consultant_JR114148-1

Applications close 8th December 2020.

 

Opportunity available for a Addiction medicine specialist in the NT

Addiction Medicine Specialist role. Providing clinical leadership to Top End Health Service on Alcohol and Other Drugs Service practice, clinical governance, service development and AOD related advice, training and support to medical and other health practitioners in hospital, community and primary health care working in the regional areas serviced by TEHS.
 
For further information click on the link to the job advertisement
 
 
Applications Close: 18/12/2020
 

APSAD 2020 WEBINAR SERIES NOW AVAILABLE TO WATCH ON DEMAND

2020 Webinar Banner v2APSAD 2020 WEBINAR SERIES NOW AVAILABLE TO WATCH ON DEMAND

Through November in place of the annual conference APSAD held a series of webinars. The 2020 Webinar Series was convened by Prof Leanne Hides with input from APSAD's members through subcommittees and special interest groups.

The Webinar Series included the annual APSAD Awards presentation ceremony, with APSAD Early Career Awardee Cheneal Puljević's presentation on Missed opportunities to reduce tobacco smoking among people who experience incarceration or homelessnessProfessor Wayne Hall delivered the keynote oration Retrospections of a Recovering Drug Researcher. The ASCP-SIG put together the annual Australasian Smoking Cessation Professionals Update Day with two 1-hour webinars, where Professor Tom Calma AO provide an Overview of the Commonwealth’s Tackling Indigenous Smoking Program: Priorities and Evaluations, and Dr Raglan Maddox looked at the continuing downward trend within Aboriginal and Torres Strait Islander smoking rates, among other great speakers and topics. The EMCR Subcommittee solicited abstracts from students and ECRs to put together a Rapid Fire session. The APSAD 2020 Webinar Series concluded with two sessions on COVID-19 and the impact it has had on people who use drugs and clinicians.

Watch the 2020 APSAD WEBINAR SERIES now as a Playlist or watch the individual webinars.

 

APSAD Office Hours during the Xmas period

The APSAD Office will be closed from Friday 18 December and will reopen on Monday 11 January.

Holly Plant Season Instagram Post

 

 

 

 

 

NHMRC ‘QUITLINK’ STUDY in Victoria Recruiting Online


From 16 November 2020 – 31 March 2021

Professor Amanda Baker from the University of Newcastle is leading a NHMRC funded study evaluating the effectiveness of commonly available forms of smoking cessation care among people receiving support or treatment for alcohol and other drug and/or mental health issues. The study is limited to people in VICTORIA.

If you are based in VICTORIA and have any clients who may be interested, please pass on this advertisement to them.

If you would like further information, please email This email address is being protected from spambots. You need JavaScript enabled to view it.

Online recruitment will be running from 16th November (closed 21st December 2020 -10th January 2021) til 31 March.

Click here to view the advertisement.

 

Opportunity for research & scholarship funding for Aboriginal and Torres Strait Islander professionals

Opportunity for research & scholarship funding for Aboriginal and Torres Strait Islander professionals (clinicians, nurses, allied health workers).

The National Centre for Clinical Research on Emerging Drugs (NCCRED) is looking to support clinical research conducted by Aboriginal and Torres Strait Islander professionals (clinicians nurses, allied health workers) working in the alcohol and other drugs sector. NCCRED has developed a Clinical Research Scholarship Program to build the scope and capacity of clinical research on emerging drugs through the provision of mentoring, research project funds, and salary buy-back. This is a national program open to clinicians at all levels, anywhere in Australia. Please contact us to discuss any ideas that you have.

Applicants to this round will should read the application pack provided and submit an Expression of Interest (EOI). Applications open 2nd October 2020 and close 6th November. For more information please visit https://nccred.org.au/generate/nccred-fellowships/

 

The Neuroscience Interest Group of International Society of Addiction Medicine (ISAM-NIG)

New monthly talk series, In love with addiction neuroscience

ISAM talk series1

For further information and to register for future talks visit their website

You can find the full recorded video of the first talk on the ISAM-NIG channel, and the slides from clicking on this link.
 

Invitation to participate in an Update of the National Comorbidity Guidelines

The Matilda Centre for Research in Mental Health and Substance Use at the University of Sydney has been funded by the Australian Government Department of Health to update and revise the ‘Guidelines on the management of co-occurring alcohol and other drug and mental health conditions in alcohol and other drug treatment settings’ (second edition).
 
Originally published in 2009, with the second edition released in 2016, this hugely popular resource aimed to provide alcohol and other drug (AOD) workers with evidence-based information on the management of comorbid mental health conditions in AOD settings. Since publication of the second edition in July 2016, 15,000 hard and electronic copies have been distributed to clinicians and treatment services across Australia.
 
Subsequent funding from the Australian Government Department of Health enabled the development of an accompanying online training program and interactive online copy of the second edition. Since the website and online training program were launched in November 2017, close to 3,500 people have begun using the program and more than 650 people have completed the full training program. The website has attracted a monthly average of approximately 3,000 visitors (>5,650 per month in 2020).
 
The revision of the second edition will bring the Guidelines up to date with the most current evidence. The project is being undertaken by Dr Christina Marel, Prof Katherine Mills, Dr Alana Fisher, Ms Erin Madden, Prof Maree Teesson, Dr Mark Deady, Prof Frances Kay-Lambkin, Prof Amanda Baker, Prof Andrew Baillie, and Prof Kevin Gournay.
 
The revision team would be delighted if members of the alcohol and other drugs sector would be interested in participating in the revision through one (or more) of the following:

  1. Attending one of online two discussion forums;
  2. Completing a short online survey;
  3. Emailing feedback about the Guidelines directly to our team.

 
Online discussion forums
The revision team are holding two online discuss forums open to anyone, and hope that that these forums will be attended by a variety of interested stakeholders including alcohol and other drug workers, clinicians, healthcare workers, consumers and people with lived experience of mental health and substance use, family members, carers as well as academic experts. Additional discussion forums may be made available depending on demand.
 
The discussion forums will be held online on
Discussion Forum 1: Tuesday 8 September 2020, from 1 to 4pm AEST,and
Discussion Forum 2: Thursday 10 September 2020, from 9am to 12pm AEST.
 
During the forums, discussion will include the content of the Guidelines with a particular focus on how the existing resource can be improved. A copy of the current edition of the Guidelines is available for download on the Comorbidity Guidelines website:  https://comorbidityguidelines.org.au/pdf/comorbidity-guideline.pdf
 
If you are interested in participating as a discussion forum member in either forum, please register below.
 
Register for Discussion Forum 1: Tuesday 8 September 2020, from 1 to 4pm AEST
https://bit.ly/cgl-discussion-forum-1
 
Register for Discussion Forum 2: Thursday 10 September 2020, from 9am to 12pm AEST
https://bit.ly/cgl-discussion-forum-2  
 
Online survey
The online survey will take around 5 minutes to complete, and will focus on the current (2nd edition) Guidelines, and areas for improvement.

The survey will remain open until 5pm (AEST) 30th September 2020.
 
Click here to complete the online survey: https://bit.ly/cgl-second-ed-feedback
 
Send feedback directly to us
 
We also welcome any other form of feedback that can be sent directly to our team.
 
Please email This email address is being protected from spambots. You need JavaScript enabled to view it. before 5pm (AEST) 30th September 2020

 

HPCA is seeking applications from registered NSW physicians and psychiatrists to become health assessors

HPCA is seeking applications from registered drug and alcohol psychiatry and physicians specialising in drug and alcohol dependence assessment and treatment located in NSW to become health assessors on the Council Directed Health Assessment List (the List).

The List includes health assessors who may be engaged to assess the health of registered health practitioners under the Health Practitioner Regulation National Law (NSW). Health assessors provide assessment reports that assist the health professional councils and impaired registrants panels to determine if a registered health practitioner is impaired under the National Law (NSW). If a registered health practitioner is impaired, further action may be recommended by the health assessor. This includes restrictions on practice and other options available to the relevant health professional council.

The List has been established to support the timely and flexible provision of health assessments across NSW. You can apply, via a single application process to work with all 15 health professional councils in NSW.You can apply for the List at any time, however in order to be considered for the first round, your application will need to be submitted by COB 31 August 2020.

 

For further information on how to apply and to complete an application form, visit hpca.nsw.gov.au/CDHAList

 

Subcategories